UB-311 Alzheimer's Vaccine — Vax-Before-Travel

UB-311 Alzheimer's Vaccine

Fact checked by Robert Carlson, MD

Aug 13

4 min read

Innovative Alzheimer's Disease Vaccine Candidate Can Add Value

Vaxxinity UB-311 immunotherapeutic vaccine targets Alzheimers dementia

Alzheimers vaccine 2023

Alzheimer’s Disease

Fact checked by John Paul Sanchez, PharmD

Jan 16

3 min read

Alzheimer’s Vaccine Candidate Shows Positive Phase 2a Results

United Neuroscience Alzheimer's vaccine UB-311 produced positive results for 96 percent of phase 2b study participants

older man painting on a canvas outside

Alzheimer’s Disease